vaccines Flashcards

1
Q

HBV Routine immunization of infants– 3 doses ?

A

Birth, 1 month, 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HBV Routine immunization for adolescents ?

A

3 doses of pediatric or

2 doses of adult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pediatric HBV ?

A

Recombivax or Engerix 0.5 ml IM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Adult HBV ?

A

Recombivax 1 ml IM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

RV5 ?

A

Rotateq

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

RV5 doses ?

A

latex-free, no reconstitution needed, 3 dose series

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

RV1 ?

A

Rotarix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

RV1 doses ?

A

has latex, must be reconstituted with diluent, possible increase risk of intussusception, 2 dose series

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

RV1 months ?

A

oral

2 and 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

RV5 months ?

A

oral

2 4 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rotavirus, dont start if ?

A

Do not start if 15 weeks or older

If infant spits it up, do not repeat dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DTaP marketed as ?

A

Daptacel, Infanrix, Tripedia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DTaP amount ?

A

0.5 mL IM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DTaP months ?

A

2, 4, 6 and 15-18 months, and 4-6 years (5 doses)

5 doses

3 months – not adequately immunized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DT ?

A

when pertussis is contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Td ?

A

tetanus toxoid and reduced amount of diphtheria, typically for adults requiring tetanus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DtaP-Hib ?

A

(TriHIBit),

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

DTaP-IPV-HepB ?

A

(Pedarix),

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

DTaP-IPV-Hib ?

A

(Pentacel),

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

DTaP-IPV ?

A

(Kinrix)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

DTaP contraindications ?

A

Anaphylactic-type reaction to previous dose

Encephalopathy within 7 days of previous dose (not attributable to another cause)

Progressive neurologic d/o

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

DTaP precautions ?

A

High fever (40.5C)

Persistent, inconsolable crying within 48⁰ of previous dose

Seizures within 3 days of previous dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

DTaP AR ?

A

Local reaction, especially with increasing number of doses

Fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

PedvaxHIB months ?

A

2, 4, and 12-15 mos

H. flu only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
ActHIB months ?
2, 4, 6 and 12-15 mos H. fu only
26
Pneumococcal conjugate vaccine (PCV13) recommendation ?
all children younger than 5 years old, all adults 65 years or older, and people 6 years or older with certain risk factors. 
27
Pneumococcal polysaccharide vaccine (PPSV23) recommendation ?
all adults 65 years or older. People 2 through 64 years old who are at high risk of pneumococcal disease should also receive PPSV23.
28
PCV13: Age at 1st dose (months): 2-6 months ?
3 doses 1 dose at 12-15 mos booster
29
PCV13: Age at 1st dose (months) 7-11 months ?
2 doses 1 dose at 12-15 mos booster
30
PCV13: Age at 1st dose (months) 12-23 months ?
2 doses no booster
31
PCV13: Age at 1st dose (months) 24-59 months in healthy children ?
1 dose no booster
32
PCV13: Age at 1st dose (months) 24-71 months in children at risk* ?
2 doses no booster
33
IPV route and months
Subcut 2, 4, and 6-18 mos and 4-6 years. ALL need a dose at 4-6 years
34
LAIV marketed as ?
Fluzone, Fluvirin, Fluarix, Afluria
35
Annual vaccination for ALL people 6 mos old and up, in the fall Each year a new formulation is made, based on surveillance in Asia ?
LAIV
36
LAIV Children 6-35 months dosing ?
0.25 mL IM, older children 0.5 mL
37
MMR given in two doses – months ?
12-15 mos and 4-6 yrs
38
MMRV higher rate of ?
seizures
39
Reconstitute with diluent, inject sub cut ?
MMR
40
Rule out pregnancy first and advise no conception for __ mos after injection for MMR
3
41
MMR contrindications ?
Pregnant, immunocompromised, egg allergy, high-dose steroids
42
MMR AR ?
Few develop fever 6-12 days later 5% get a rash Rare – encephalitis, Guillain- Barre (1 in 3 million) Febrile seizure, esp if MMRV
43
VAR marketed as ?
Varivax
44
VAR store in ?
freezer
45
VAR need to be reconstituted , T or F ?
T
46
VAR dosing schedule ?
12-15 mos and 4-6 years | May do MMRV for 2nd dose
47
VAR contraindications ?
Severe allergic reaction to previous dose Immunodeficient Pregnant women
48
VAR precaution ?
Personal or family hx of febrile seizures
49
VAR AR ?
20% get minor injection site reactions Rash
50
HepA for ?
children travelers to countries with high rates of Hep A children with Hep B or Hep C infection children with clotting disorders adolescent/adult males who have sex with men occupational exposure illegal drug users close contact with international adoptee 2-18 yo if previously unimmunized
51
HepA marketed as ?
Havrix or Vaqta
52
HepA doses and route ?
2 dose IM
53
HepA 1-18 years ?
0.5 mL, 6-18 mos apart
54
HepA 19+ years ?
1.0 mL, 6-18 mos apart
55
HepA contrindications ?
Allergic reaction to previous dose
56
HepA precautions ?
Pregnant Moderate/severe illness
57
HepA AR ?
Uncommon and mild – injection site pain, HA, loss of appetite
58
Meningococcal Vaccine serogroups ?
A, B, C, W-135 and Y
59
Meningococcal Vaccine serogroups that predominate in the US ?
B C Y
60
No vaccine for serogroup __ ?
B
61
Two MCV4 vaccines available – ?
Menactra and Menveo
62
MCV4 for who ?
For all people 11-12 years, booster dose at age 16 years Earlier and more frequent doses for those at risk
63
MCV4 dosing ?
0.5
64
Neisseria meningitidis who is at risk ?
College freshmen living in dorms Military recruits People who travel to or live in countries with high rates of meningococcal disease People with complement deficiency People with functional or anatomic asplenia Immunocompromised people so give them the MCV4 vaccine
65
MCV 4 contrindications ?
Allergic reaction to vaccine or diphtheria toxoid
66
MCV4 precautions ?
Okay to give to immunosuppressed patients
67
MCV4 AR ?
Injection site pain 4.3% get more systemic reactions – fever, HA, fatigue, malaise, arthralgias, vomiting, diarrhea, rash, seizures
68
Meningitis Exposure ?
Post-exposure prophylaxis for close contacts Within 24 hours Rifampin, ceftriaxone, maybe cipro
69
Tdap – marketed as ?
Boostrix, Adacel
70
Tdap 11-18 yo doses ?
0.5 mL IM INSTEAD OF the Td booster
71
Tdap 19-64 y.o. dosing ?
single dose of Tdap
72
Tdap 65+ yo. dosing ?
single dose of Tdap if not previously dosed and if will have contact with an infant
73
Tdap contrindications ?
allergy
74
Tdap precautions ?
Guillain-Barre within 6 wks of previous tetanus vaccine
75
Tdap AR ?
local pain, HA, fatigue
76
Most common STI in US ?
HPV
77
HPV: Types 16 and 18 cause 70% of ?
cervical cancers
78
HPV: Types 6 and 11 cause 90% of ?
genital warts
79
HPV dosing and months ?
3 doses, 0.5 mL IM 0, 2 and 6 months
80
HPV they can start when ?
Can start as early as 9 2 doses for 9-14 yo (6 months apart)
81
HPV recommendation ?
all 11- 12 yrs and through 26 yo if not previously immunized 3 doses
82
Other Vaccines ?
``` Rabies Vaccine Typhoid Fever Vaccine Japanese Encephalitis Vaccine Tuberculosis Vaccine Yellow Fever Vaccine ```